Regencell Bioscience Holdings Financial Ratios for Analysis 2019-2024 | RGC

Fifteen years of historical annual and quarterly financial ratios and margins for Regencell Bioscience Holdings (RGC).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202420232022202120202019
41.9219.1528.460.020.120.12
------
----0.92-1.16-1.13
------
------
------
------
------
------
------
------
------
------
-53.09-50.56-44.4633.6930.6521.27
-53.09-50.56-44.4633.6930.6521.27
-51.71-48.03-42.15-395.95-158.04-160.70
-53.09-50.56-44.4633.6930.6521.27
0.630.921.31-0.40-0.27-0.15
-0.31-0.38-0.41-0.08-0.07-0.04
-0.31-0.38-0.47-0.08-0.08-0.04

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-30
------
------
------
------
------
------
------
------
------
------
------
------
------
------
------
------
------
------
0.000.000.000.000.000.00
------